Rhythm Pharmaceuticals Inc (RYTM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2023 | 09-2023 | 06-2023 | 03-2023 | 12-2022 | |
| Sales | 24,234 | 22,504 | 19,221 | 11,469 | 8,790 |
| Cost of Goods | 3,233 | 2,412 | 2,236 | 1,421 | 1,028 |
| Gross Profit | 21,001 | 20,092 | 16,985 | 10,048 | 7,762 |
| Operating Expenses | 62,503 | 64,457 | 63,825 | 63,000 | 49,893 |
| Operating Income | -41,269 | -43,953 | -46,604 | -52,531 | -42,103 |
| Interest Expense | 4,379 | 3,149 | 3,303 | 3,061 | 3,011 |
| Other Income | 4,211 | 3,307 | 3,204 | 3,413 | 2,621 |
| Pre-tax Income | -41,437 | -43,795 | -46,703 | -52,179 | -42,493 |
| Income Tax | 196 | 368 | N/A | N/A | N/A |
| Net Income Continuous | -41,633 | -44,163 | -46,703 | -52,179 | -42,493 |
| Net Income | $-41,633 | $-44,163 | $-46,703 | $-52,179 | $-42,493 |
| EPS Basic Total Ops | -0.70 | -0.76 | -0.82 | -0.92 | -0.74 |
| EPS Basic Continuous Ops | -0.70 | -0.76 | -0.82 | -0.92 | -0.74 |
| EPS Diluted Total Ops | -0.70 | -0.76 | -0.82 | -0.92 | -0.74 |
| EPS Diluted Continuous Ops | -0.70 | -0.76 | -0.82 | -0.92 | -0.74 |
| EBITDA(a) | $-40,852 | $-43,511 | $-49,223 | $-49,013 | $-43,851 |